• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一株与志贺样毒素II(VT2)具有免疫相关性的人源大肠杆菌中纯化出一种Vero毒素及其某些特性。

Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).

作者信息

Oku Y, Yutsudo T, Hirayama T, O'Brien A D, Takeda Y

机构信息

Department of Bacterial Infection, Institute of Medical Science, University of Tokyo, Japan.

出版信息

Microb Pathog. 1989 Feb;6(2):113-22. doi: 10.1016/0882-4010(89)90014-4.

DOI:10.1016/0882-4010(89)90014-4
PMID:2654533
Abstract

A cytotoxin to Vero cells (Vero toxin), which was immunologically related to Shiga-like toxin II (SLT-II) (or VT2), was purified from a stain of Escherichia coli isolated from a patient with hemolytic uremic syndrome. The toxin was active on Vero cells but much less active on HeLa cells, a property similar to that of the recently identified SLT-II variant from E. coli strains that caused edema disease of swine. Thus the toxin purified in this report was tentatively named Shiga-like toxin II variant (Vero toxin 2 variant). The purification procedures consisted of ammonium sulfate fractionation, DEAE-Sepharose CL-6B column chromatography, chromatofocusing column chromatography, and repeated high performance liquid chromatography (HPLC) on TSK-gel G-2000SW column and on TSK-gel DEAE-5PW columns. About 90 micrograms of purified toxin was obtained from 451 of the culture supernatant with a yield of about 16%. The purified toxin consisted of A and B subunits of molecular sizes similar to those of SLT-II (VT2). The isoelectric point of the purified toxin was 6.1, which was different from that of SLT-II (VT2) (pI = 4.1). In an Ouchterlony double gel diffusion test, purified toxin and SLT-II (VT2) formed precipitin lines with spur formation against anti-purified toxin and anti-SLT-II (anti-VT2), respectively. The purified toxin was cytotoxic to Vero cells, about 6 pg of the toxin killing 50% of the Vero cells, and showed lethal toxicity to mice when injected intraperitoneally, the LD50 being about 2.7 ng per mouse.

摘要

从一名溶血尿毒综合征患者分离出的大肠杆菌菌株中纯化出一种对Vero细胞有细胞毒性的毒素(Vero毒素),它与志贺样毒素II(SLT-II,或VT2)在免疫学上相关。该毒素对Vero细胞有活性,但对HeLa细胞的活性要低得多,这一特性与最近从引起猪水肿病的大肠杆菌菌株中鉴定出的SLT-II变体相似。因此,本报告中纯化的毒素被暂命名为志贺样毒素II变体(Vero毒素2变体)。纯化步骤包括硫酸铵分级分离、DEAE-琼脂糖CL-6B柱色谱、色谱聚焦柱色谱,以及在TSK-gel G-2000SW柱和TSK-gel DEAE-5PW柱上重复进行高效液相色谱(HPLC)。从451升培养上清液中获得了约90微克的纯化毒素,产率约为16%。纯化的毒素由分子大小与SLT-II(VT2)相似的A和B亚基组成。纯化毒素的等电点为6.1,与SLT-II(VT2)的等电点(pI = 4.1)不同。在双向琼脂扩散试验中,纯化毒素和SLT-II(VT2)分别与抗纯化毒素和抗SLT-II(抗VT2)形成了带有刺突的沉淀线。纯化毒素对Vero细胞具有细胞毒性,约6皮克毒素可杀死50%的Vero细胞,腹腔注射时对小鼠显示出致死毒性,半数致死量约为每只小鼠2.7纳克。

相似文献

1
Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).从一株与志贺样毒素II(VT2)具有免疫相关性的人源大肠杆菌中纯化出一种Vero毒素及其某些特性。
Microb Pathog. 1989 Feb;6(2):113-22. doi: 10.1016/0882-4010(89)90014-4.
2
Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin.来自大肠杆菌O157:H7的一种与志贺毒素无免疫相关性的维罗毒素的纯化及某些特性
Microb Pathog. 1987 Jul;3(1):21-30. doi: 10.1016/0882-4010(87)90034-9.
3
Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.来自大肠杆菌O157:H7的志贺样毒素的纯化及其一些特性,该毒素在免疫上与志贺毒素相同。
Microb Pathog. 1987 May;2(5):339-49. doi: 10.1016/0882-4010(87)90076-3.
4
Purification and some properties of a Vero toxin 2 (Shiga-like toxin II) variant (SLT-IIva) of Escherichia coli isolated from infantile diarrhea.从婴儿腹泻中分离出的大肠杆菌维罗毒素2(志贺样毒素II)变体(SLT-IIva)的纯化及某些特性
Microb Pathog. 1993 Nov;15(5):399-405. doi: 10.1006/mpat.1993.1089.
5
The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.通过Vero细胞细胞毒性测定时,肠出血性大肠杆菌的II型志贺样毒素(SLT-II)及与SLT-II相关毒素的比活性有所不同,但通过小鼠致死率测定时则无差异。
Infect Immun. 1994 Feb;62(2):623-31. doi: 10.1128/iai.62.2.623-631.1994.
6
Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.志贺样毒素 II 的亲和纯化与表征及毒素特异性单克隆抗体的制备
Infect Immun. 1988 Aug;56(8):1926-33. doi: 10.1128/iai.56.8.1926-1933.1988.
7
Purification and characterization of an Escherichia coli Shiga-like toxin II variant.大肠杆菌志贺样毒素II变体的纯化与特性分析
Infect Immun. 1990 May;58(5):1232-9. doi: 10.1128/iai.58.5.1232-1239.1990.
8
Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli O157:H7.
Microb Pathog. 1988 Sep;5(3):189-95. doi: 10.1016/0882-4010(88)90021-6.
9
Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome.从一名溶血尿毒综合征患者分离出的大肠杆菌O91:H21中Vero毒素2变体基因的克隆与核苷酸测序
Microb Pathog. 1990 Jan;8(1):47-60. doi: 10.1016/0882-4010(90)90007-d.
10
Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.来自引起猪水肿病的大肠杆菌菌株的II型志贺样毒素变体的克隆与测序
J Bacteriol. 1988 Sep;170(9):4223-30. doi: 10.1128/jb.170.9.4223-4230.1988.

引用本文的文献

1
A Comprehensive Review on Shiga Toxin Subtypes and Their Niche-Related Distribution Characteristics in Shiga-Toxin-Producing and Other Bacterial Hosts.关于志贺毒素亚型及其在产志贺毒素细菌和其他细菌宿主中与生态位相关的分布特征的综合综述
Microorganisms. 2024 Mar 28;12(4):687. doi: 10.3390/microorganisms12040687.
2
Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition.基于亲和力的四价肽筛选通过靶向志贺毒素2d(一种高毒力亚型)受体识别中涉及的独特氨基酸,鉴定出该亚型选择性中和剂。
Infect Immun. 2016 Aug 19;84(9):2653-61. doi: 10.1128/IAI.00149-16. Print 2016 Sep.
3
A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli.
一步法从致病性大肠杆菌中纯化和分子特征分析功能性志贺毒素 2 变体。
Toxins (Basel). 2012 Jul;4(7):487-504. doi: 10.3390/toxins4070487. Epub 2012 Jun 25.
4
Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel.改良志贺氏菌O特异性多糖-蛋白结合疫苗在以色列成年人中的安全性和免疫原性。
Infect Immun. 2001 Mar;69(3):1351-7. doi: 10.1128/IAI.69.3.1351-1357.2001.
5
Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.干酪乳杆菌代田株对产志贺毒素大肠杆菌O157:H7感染幼兔的保护作用。
Infect Immun. 2001 Feb;69(2):1101-8. doi: 10.1128/IAI.69.2.1101-1108.2001.
6
Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice.用琥珀酸酐处理可提高福氏志贺菌2a型O特异性多糖-蛋白偶联物在小鼠体内的免疫原性。
Infect Immun. 1999 Oct;67(10):5526-9. doi: 10.1128/IAI.67.10.5526-5529.1999.
7
Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates.在人和动物大肠杆菌分离株中鉴定新的2型志贺毒素变异体B亚基基因。
J Clin Microbiol. 1998 Nov;36(11):3317-22. doi: 10.1128/JCM.36.11.3317-3322.1998.
8
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.产志贺毒素大肠杆菌感染的发病机制与诊断
Clin Microbiol Rev. 1998 Jul;11(3):450-79. doi: 10.1128/CMR.11.3.450.
9
The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.通过Vero细胞细胞毒性测定时,肠出血性大肠杆菌的II型志贺样毒素(SLT-II)及与SLT-II相关毒素的比活性有所不同,但通过小鼠致死率测定时则无差异。
Infect Immun. 1994 Feb;62(2):623-31. doi: 10.1128/iai.62.2.623-631.1994.
10
An enzyme-linked immunosorbent assay-based isolation procedure for verotoxigenic Escherichia coli.一种基于酶联免疫吸附测定的产志贺毒素大肠杆菌分离程序。
Appl Environ Microbiol. 1993 Dec;59(12):4223-9. doi: 10.1128/aem.59.12.4223-4229.1993.